FREMONT, Calif. — Neuralink is opening a new clinical trial aimed at decoding intended speech directly from the brain, a step that would extend its implant beyond moving cursors and toward giving a voice back to people who have lost the ability to speak.
The effort targets patients with conditions such as ALS and severe paralysis, who may retain the intention to speak even as the muscles that produce speech fail. If the implant can translate those neural signals into words quickly and accurately, it could become one of the most consequential applications of brain-computer interfaces yet attempted.
Beyond the Cursor
Neuralink's early public milestones centered on control: participants moving a cursor, clicking, playing games and operating software with thought alone. That work has advanced quickly, with the company recently setting a cursor-control record built on 50,000 hours of brain data gathered across its participants.
Speech is the natural next frontier. Decoding intended words is harder than tracking a cursor because language is faster, higher-dimensional and deeply personal. But the same high-channel-count implant and machine-learning pipeline that made precise cursor control possible are what the company now hopes to point at the problem of communication.
How It Would Work
In the trial, the implant reads activity from the regions of the brain involved in producing speech, and software translates those patterns into text or synthesized audio in close to real time. The goal is a system that keeps up with natural conversation rather than forcing users to spell out words letter by letter, which is how many existing assistive tools work.

